Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Reviva Pharmaceuticals Holdings, Inc. | StockGist | StockGist

Companies
RVPH
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings RVPHSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Reviva Pharmaceuticals Holdings, Inc.

Filed Feb 14, 2025

Accepted Feb 13, 2025, 7:00 PM ET

CIK 0001742927

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

46,579,199

Reporting Person

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Person Type

IA

CUSIP: 76152G100

Amendment History

8 filings

SCHEDULE 13G
Original
Sep 29, 20250000921895-25-002634
SCHEDULE 13G/A
Amendment 1
Feb 7, 20250001649553-25-000043
SCHEDULE 13G/A
Amendment 2
Viewing
Feb 14, 20250001193805-25-000195
SCHEDULE 13G/A
Amendment 3
May 15, 20250001214659-25-007880
SCHEDULE 13G/A
Amendment 4
Aug 14, 20250001649553-25-000160
SCHEDULE 13G/A
Amendment 5
Aug 14, 20250001214659-25-012270
SCHEDULE 13G/A
Amendment 6
Jan 16, 20260001104659-26-004596
SCHEDULE 13G/A
Amendment 7
Latest
Feb 17, 20260000921895-26-000468

Key Facts

Shares Owned

46,579,199

Recent Filings

Reviva Pharmaceuticals Holdings, Inc.1 weeks ago

Reviva Pharmaceuticals Holdings, Inc.1 weeks ago

Reviva Pharmaceuticals Holdings, Inc.1 weeks ago

Reviva Pharmaceuticals Holdings, Inc.2 weeks ago

Reviva Pharmaceuticals Holdings, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice